APO Research
Talk to an analyst

APO RESEARCH · REPORT

Selpercatinib Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Selpercatinib Capsules Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchSelpercatinib Capsules Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Selpercatinib Capsules Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Selpercatinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Selpercatinib Capsules Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Selpercatinib Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Selpercatinib Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Selpercatinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Selpercatinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Selpercatinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Selpercatinib Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Selpercatinib Capsules market include Innovnent Biologics and Eli Lilly among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Selpercatinib Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Selpercatinib Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Selpercatinib Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Selpercatinib Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Selpercatinib Capsules Segment by Company

Innovnent Biologics

Eli Lilly

Selpercatinib Capsules Segment by Type

40mg

80mg

Selpercatinib Capsules Segment by Application

Thyroid Carcinoma

Non-Small Cell Lung Cancer (NSCLC)

Others

Selpercatinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Selpercatinib Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Selpercatinib Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Selpercatinib Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Selpercatinib Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Selpercatinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Selpercatinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Selpercatinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Selpercatinib Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Selpercatinib Capsules industry.

Chapter 3: Detailed analysis of Selpercatinib Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Selpercatinib Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Selpercatinib Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Selpercatinib Capsules Industry Trends Table 2. Selpercatinib Capsules Industry Drivers Table 3. Selpercatinib Capsules Industry Opportunities and Challenges Table 4. Selpercatinib Capsules Industry Restraints Table 5. Global Selpercatinib Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Selpercatinib Capsules Revenue Share by Company (2021-2026) Table 7. Global Selpercatinib Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Selpercatinib Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Selpercatinib Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Selpercatinib Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Selpercatinib Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Selpercatinib Capsules Company, Product Type & Application Table 13. Global Selpercatinib Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Selpercatinib Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg Table 18. Significant Companies of 80mg Table 19. Global Selpercatinib Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Selpercatinib Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Selpercatinib Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Selpercatinib Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Selpercatinib Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Selpercatinib Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Selpercatinib Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Selpercatinib Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Selpercatinib Capsules Sales Value Share by Type (2021-2026) Table 28. Global Selpercatinib Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Thyroid Carcinoma Table 30. Significant Companies of Non-Small Cell Lung Cancer (NSCLC) Table 31. Significant Companies of Others Table 32. Global Selpercatinib Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Selpercatinib Capsules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Selpercatinib Capsules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Selpercatinib Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Selpercatinib Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Selpercatinib Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Selpercatinib Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Selpercatinib Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Selpercatinib Capsules Sales Value Share by Application (2021-2026) Table 41. Global Selpercatinib Capsules Sales Value Share by Application (2027-2032) Table 42. Global Selpercatinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Selpercatinib Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Selpercatinib Capsules Sales Market Share by Region (2021-2026) Table 45. Global Selpercatinib Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Selpercatinib Capsules Sales Market Share by Region (2027-2032) Table 47. Global Selpercatinib Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Selpercatinib Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Selpercatinib Capsules Sales Value Share by Region (2021-2026) Table 50. Global Selpercatinib Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Selpercatinib Capsules Sales Value Share by Region (2027-2032) Table 52. Global Selpercatinib Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Selpercatinib Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Selpercatinib Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Selpercatinib Capsules Sales by Country (2021-2026) & (K Units) Table 57. Global Selpercatinib Capsules Sales Market Share by Country (2021-2026) Table 58. Global Selpercatinib Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Selpercatinib Capsules Sales Market Share by Country (2027-2032) Table 60. Global Selpercatinib Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Selpercatinib Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Selpercatinib Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Selpercatinib Capsules Sales Value Market Share by Country (2027-2032) Table 64. Innovnent Biologics Company Information Table 65. Innovnent Biologics Business Overview Table 66. Innovnent Biologics Selpercatinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Innovnent Biologics Selpercatinib Capsules Product Portfolio Table 68. Innovnent Biologics Recent Development Table 69. Eli Lilly Company Information Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Selpercatinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eli Lilly Selpercatinib Capsules Product Portfolio Table 73. Eli Lilly Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Selpercatinib Capsules Distributors List Table 77. Selpercatinib Capsules Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Selpercatinib Capsules Product Image Figure 2. Global Selpercatinib Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Selpercatinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Selpercatinib Capsules Sales (2021-2032) & (K Units) Figure 5. Global Selpercatinib Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Selpercatinib Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg Image Figure 10. 80mg Image Figure 11. Global Selpercatinib Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Selpercatinib Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Selpercatinib Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Selpercatinib Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Selpercatinib Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Selpercatinib Capsules Sales Value Share by Type (2021-2032) Figure 17. Thyroid Carcinoma Image Figure 18. Non-Small Cell Lung Cancer (NSCLC) Image Figure 19. Others Image Figure 20. Global Selpercatinib Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Selpercatinib Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Selpercatinib Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Selpercatinib Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Selpercatinib Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Selpercatinib Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Selpercatinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Selpercatinib Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Selpercatinib Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Selpercatinib Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Selpercatinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Selpercatinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Selpercatinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Selpercatinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Selpercatinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Selpercatinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Selpercatinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Selpercatinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Selpercatinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Selpercatinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Selpercatinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Selpercatinib Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Selpercatinib Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Thyroid Carcinoma
  • Non-Small Cell Lung Cancer (NSCLC)
  • Others
Companies covered
  • Innovnent Biologics
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Selpercatinib Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Selpercatinib Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Selpercatinib Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Selpercatinib Capsules Market Dynamics
  1. 2.1 Selpercatinib Capsules Industry Trends
  2. 2.2 Selpercatinib Capsules Industry Drivers
  3. 2.3 Selpercatinib Capsules Industry Opportunities and Challenges
  4. 2.4 Selpercatinib Capsules Industry Restraints
3 Selpercatinib Capsules Market by Company
  1. 3.1 Global Selpercatinib Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Selpercatinib Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Selpercatinib Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Selpercatinib Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Selpercatinib Capsules Company Ranking (2024-2026)
  6. 3.6 Global Selpercatinib Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Selpercatinib Capsules Company Product Type and Application
  8. 3.8 Global Selpercatinib Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Selpercatinib Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Selpercatinib Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Selpercatinib Capsules Market by Type
  1. 4.1 Selpercatinib Capsules Type Introduction
  2. 4.1.1 40mg
  3. 4.1.2 80mg
  4. 4.2 Global Selpercatinib Capsules Sales Volume by Type
  5. 4.2.1 Global Selpercatinib Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Selpercatinib Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Selpercatinib Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Selpercatinib Capsules Sales Value by Type
  9. 4.3.1 Global Selpercatinib Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Selpercatinib Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Selpercatinib Capsules Sales Value Share by Type (2021-2032)
5 Selpercatinib Capsules Market by Application
  1. 5.1 Selpercatinib Capsules Application Introduction
  2. 5.1.1 Thyroid Carcinoma
  3. 5.1.2 Non-Small Cell Lung Cancer (NSCLC)
  4. 5.1.3 Others
  5. 5.2 Global Selpercatinib Capsules Sales Volume by Application
  6. 5.2.1 Global Selpercatinib Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Selpercatinib Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Selpercatinib Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Selpercatinib Capsules Sales Value by Application
  10. 5.3.1 Global Selpercatinib Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Selpercatinib Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Selpercatinib Capsules Sales Value Share by Application (2021-2032)
6 Selpercatinib Capsules Regional Sales and Value Analysis
  1. 6.1 Global Selpercatinib Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Selpercatinib Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Selpercatinib Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Selpercatinib Capsules Sales by Region (2027-2032)
  5. 6.3 Global Selpercatinib Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Selpercatinib Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Selpercatinib Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Selpercatinib Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Selpercatinib Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Selpercatinib Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Selpercatinib Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Selpercatinib Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Selpercatinib Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Selpercatinib Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Selpercatinib Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Selpercatinib Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Selpercatinib Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Selpercatinib Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Selpercatinib Capsules Sales Value Share by Country, 2025 VS 2032
7 Selpercatinib Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Selpercatinib Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Selpercatinib Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Selpercatinib Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Selpercatinib Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Selpercatinib Capsules Sales by Country (2027-2032)
  6. 7.4 Global Selpercatinib Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Selpercatinib Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Selpercatinib Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Selpercatinib Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Selpercatinib Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Selpercatinib Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Innovnent Biologics
  2. 8.1.1 Innovnent Biologics Company Information
  3. 8.1.2 Innovnent Biologics Business Overview
  4. 8.1.3 Innovnent Biologics Selpercatinib Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Innovnent Biologics Selpercatinib Capsules Product Portfolio
  6. 8.1.5 Innovnent Biologics Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Selpercatinib Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Selpercatinib Capsules Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Selpercatinib Capsules Value Chain Analysis
  2. 9.1.1 Selpercatinib Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Selpercatinib Capsules Sales Mode & Process
  6. 9.2 Selpercatinib Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Selpercatinib Capsules Distributors
  9. 9.2.3 Selpercatinib Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst